Quest Diagnostics Q2 revenues up 2%; earnings down 6%

Quest Diagnostics (NYSE:DGX) Q2 results ($M): Revenues: 1,953 (+1.8%).

Net income: 206 (-5.9%); non-GAAP net income: 237 (-3.3%); EPS: 1.51 (-3.8%); non-GAAP EPS: 1.73 (-1.1%).

Cash flow ops: 321 (-0.6%).

2019 guidance: Revenues: $7.60B – 7.75B (unch); EPS: >$5.29 from >$5.16; non-GAAP EPS: >$6.40 (unch); cash flow ops: ~$1.3B (unch).

Previously: Quest Diagnostics EPS beats by $0.05, beats on revenue (July 23)

https://seekingalpha.com/news/3480032-quest-diagnostics-q2-revenues-2-percent-earnings-6-percent